by priyatham | Oct 22, 2017 | Prescription Advisory Blog
Medscape’s Robert Lowes recently published an article detailing opioids’ prominent role in medication malpractice claims. Much of the press around the opioid crisis covers the deaths, hospitalizations, and substance use disorder problems. All of these can...
by priyatham | Feb 9, 2017 | Prescription Advisory Blog
Route 50 talks about the importance of maps in telling the story of the opioid epidemic and how it can help public officials in particular drive home the point. Sometimes a picture is worth far more than 1,000 words. One of the challenges I see is the huge amount of...
by priyatham | Feb 1, 2017 | Prescription Advisory Blog
Here is an example of the Board of Medical Examiners using PDMP history in the complaint process resulting in the practice shutting down. The record of PDMP checks is there, and a few states are starting to look at their mandated use requirements and the gaps between...
by priyatham | Jan 24, 2017 | Prescription Advisory Blog
BMJ recently published an analysis of opioid prescribing among Medicare patients -“Opioid prescribering by multiple providers in Medicare: retrospective observational study of insurance claims”. A couple of things jumped out: Just over two thirds of opioid...
by priyatham | Jan 18, 2017 | Prescription Advisory Blog
Dr. Vivek H. Murthy, our Surgeon General, recently released a report that, among other things, highlights the gap between the widespread substance use disorder problems the country faces and the relatively small amount of abuse treatment. Here’s an excerpt from...
by priyatham | Jul 30, 2015 | Prescription Advisory Blog
Governor Chris Christie signed a bill on July 20th, 2015 requiring drug prescribers and pharmacists in NJ to register for the state’s Prescription Monitoring Program (PMP) and to check the PMP when prescribing controlled substances. “We’re not only...
